Kraft, M., Büscher, A., Wiedmann, F. T., L'Hoste, Y., Haefeli, W. E., Frey, N., . . . Schmidt, C. (2021). Current drug treatment strategies for atrial fibrillation and TASK-1 inhibition as an emerging novel therapy option. Frontiers in pharmacology, 12, . https://doi.org/10.3389/fphar.2021.638445
Chicago-Zitierstil (17. Ausg.)Kraft, Manuel, Antonius Büscher, Felix Tobias Wiedmann, Yannick L'Hoste, Walter E. Haefeli, Norbert Frey, Hugo Katus, und Constanze Schmidt. "Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option." Frontiers in Pharmacology 12 (2021). https://doi.org/10.3389/fphar.2021.638445.
MLA-Zitierstil (9. Ausg.)Kraft, Manuel, et al. "Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option." Frontiers in Pharmacology, vol. 12, 2021, https://doi.org/10.3389/fphar.2021.638445.